Načítá se...
Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway
Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. Currently, no drug is able to cure breast cancer–associated bone metastasis. In this study, we focused on statins that are known to inhibit cholesterol p...
Uloženo v:
| Vydáno v: | FASEB J |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Federation of American Societies for Experimental Biology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894072/ https://ncbi.nlm.nih.gov/pubmed/31585508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201901388R |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|